Doctors warn of risks from 'DIY Botox' as pre-mixed Innotox circulates online
Physicians caution that self-injection, counterfeit products and lack of FDA oversight can cause facial paralysis, infection and rare life‑threatening complications
Doctors and cosmetic specialists are raising alarms about a growing social media trend in which people self-inject a ready-to-use botulinum toxin product called Innotox, warning that the practice can lead to disfigurement, infection and, in rare cases, life‑threatening complications.
Thousands of user-generated videos on platforms such as TikTok show people marking their faces and injecting themselves with Innotox, a liquid formulation containing botulinum toxin type A. Unlike onabotulinumtoxinA — the prescription form of Botox that is supplied as a dehydrated powder and must be diluted by a licensed clinician — Innotox is sold in pre-mixed vials and is not approved by the U.S. Food and Drug Administration, according to reporting by the Daily Mail.
Innotox was developed by South Korea’s Medytox Inc. in 2013 as the first ready‑to‑use liquid formulation of botulinum toxin, the Daily Mail report said. It is available for purchase from a number of online outlets at far lower prices than clinical treatments: the report cited a roughly $60 price for a 100‑unit vial of Innotox compared with about $1,000 for a full‑face treatment administered by a dermatologist or licensed aesthetic provider. Typical clinical dosing varies by area treated, from a few units for small lifts to dozens for wider facial treatment.
Medical specialists said the social media trend of self-injection is especially concerning because safe administration requires detailed knowledge of facial anatomy, sterile technique and the ability to manage complications. "This product is sold illegally in the US and has not been tested or reviewed for safety and effectiveness by the FDA," New York cosmetic dermatologist Dr. Michele Green told the Daily Mail. "Its rising popularity on social media and the trend of self-injection create significant risks, as this substance cannot be safely injected just anywhere in the body and should only be administered by a licensed professional."
Complications from improperly placed or dosed botulinum toxin injections range from common and reversible effects such as bruising, localized swelling and unintended weakness in nearby muscles, to rarer but more serious problems. Hitting a blood vessel can cause a hematoma; striking a nerve can lead to temporary numbness or muscle weakness. Experts cited by the Daily Mail also warned of drooping eyelids, asymmetric brows, a puffy or "frozen" appearance and prolonged dysfunction if adverse effects are caused by a longer‑acting product.
Dr. Mo Akhavani, co‑founder of The Plastic Surgery Group, told the Daily Mail that people who self-inject face risks they cannot manage at home, including severe allergic reactions and anaphylactic shock. "When this happens at home you will not have the response kit needed which means it could be deadly," he said. He added that incorrect injections can cause permanent nerve damage, chronic pain or long‑lasting cosmetic deformity.
Physicians also warned about counterfeit or unregulated products sold online. Unregulated vials may be contaminated, contain incorrect dosages or include unknown ingredients, increasing the risk of severe illness, disfigurement and botulism — a condition in which the toxin spreads beyond the injection site. The Daily Mail report noted that botulism can lead to paralysis and death in severe cases, and cited that up to one in 10 cases of botulism have been fatal.
The Daily Mail published images and videos from social media showing people who said they self-injected, including a woman pictured with a droopy eyelid and others who showed swelling or irregular contours. In those instances, the outlet reported that it was not always clear where or how the treatments were obtained.
Regulators and medical societies have long maintained that prescription neuromodulators should be administered by licensed professionals who can screen patients, use sterile technique, target specific muscles and manage adverse events. Doctors quoted in the report urged consumers to avoid purchasing injectable neuromodulators online and to seek treatment from board‑certified dermatologists, plastic surgeons or other qualified clinicians.
The trend highlights broader tensions between demand for cosmetic treatments, social media influence and access to regulated care. Medical experts say lower cost and ease of purchase are driving the popularity of do‑it‑yourself injections, but emphasize that the immediate savings can be outweighed by the medical risks and potential for long‑term harm.